Benefits of Vitamin D

Evidence-Based Benefits

• Respiratory infection prevention — a landmark BMJ meta-analysis by Martineau et al. (2017) of 25 RCTs (n=11,321) found vitamin D supplementation reduced acute respiratory tract infections by 12% overall and by 70% in individuals with baseline 25(OH)D levels below 25 nmol/L
• Antimicrobial peptide induction — vitamin D activates the production of cathelicidin (LL-37) and beta-defensins, endogenous antimicrobial peptides that directly kill bacteria, viruses, and fungi on mucosal surfaces
• Immune regulation — vitamin D shifts T-cell responses from pro-inflammatory Th1/Th17 toward regulatory T-cells (Tregs), helping prevent the excessive inflammation that causes tissue damage during infections
• Macrophage activation — vitamin D enhances macrophage phagocytic capacity and autophagy, improving the ability of these innate immune cells to engulf and destroy pathogens
• Cytokine balance — adequate vitamin D status reduces excessive production of inflammatory cytokines (IL-6, TNF-alpha) while promoting anti-inflammatory IL-10, helping prevent cytokine storm-like responses

What the Research Says

The evidence for vitamin D in immune function is exceptionally strong. Martineau et al. (2017) published a participant-level meta-analysis in the BMJ covering 25 RCTs with 11,321 participants, demonstrating that vitamin D supplementation significantly reduced acute respiratory infections, with the greatest benefit in those with the lowest baseline levels. Aranow (2011) reviewed the immunological mechanisms, confirming that vitamin D receptors are expressed on B cells, T cells, monocytes, and dendritic cells, and that vitamin D induces cathelicidin — an antimicrobial peptide with direct bactericidal and antiviral activity. The global prevalence of vitamin D insufficiency makes this one of the most impactful and cost-effective immune interventions available.

Related Conditions